LSU Health New Orleans Research Quantifies Effect of Chronic Diseases on Racial Disparity in COVID-Associated Hospitalizations
First-of-its-Kind Study Offers Compelling Evidence
September 12, 2023
“Our research findings offer compelling evidence, underscoring that longstanding racial health discrepancies, particularly in chronic disease management, substantially contribute to the significantly higher COVID-19-associated hospitalization rates among non-Hispanic Black cancer patients than their non-Hispanic White counterparts,” notes Dr. Wu.
Cancer patients are at increased risk for severe complications from COVID-19 due to factors like aging, immunosuppression, and having other diseases or medical conditions at the same time. They have experienced notably higher COVID-associated hospitalization and overall mortality rates than the general population. Research has also shown that African-American cancer patients have higher odds of COVID-associated hospitalizations and worse outcomes than their white counterparts.This retrospective study was based on data from LSU Health New Orleans’ Louisiana Tumor Registry and the Louisiana Department of Health. The researchers first linked the data on Louisiana residents aged 20 and older and diagnosed with first primary cancer cases between 2015 and 2019 with the COVID-19 data to identify cancer patients who tested positive for COVID-19 by RT-PCR or antigen test in 2020. Then, they linked cancer patients who tested positive for COVID-19 with the 2020 statewide hospital inpatient discharge data to identify those with COVID-associated hospitalizations.
Of 6,381 cancer patients who tested positive for COVID-19, 31.6% were non-Hispanic Black cancer patients. They had a higher prevalence of chronic diseases than non-Hispanic White cancer patients (79.5% vs. 66.0%) and higher COVID-associated hospitalization (27.2% vs. 17.2%). The odds of COVID-associated hospitalizations were 80% higher for non-Hispanic Black cancer patients than non-Hispanic White cancer patients. Non-Hispanic Black cancer patients were younger and had a higher percentage of Medicaid. They were more than twice as likely to live in high-poverty areas.“This article stands as a fruitful outcome arising from a collaborative effort across diverse entities, including LSU Health New Orleans’ Louisiana Tumor Registry, Stanley Scott Cancer Center, and School of Medicine, and the Louisiana Department of Health,” adds Dr. Wu. "Dr. Augusto Ochoa has been instrumental in driving this collaborative study forward. I hope our research findings will propel multi-faceted endeavors to address the root causes of racial differences in health disparity, including chronic disease management.”
LSU Health New Orleans authors include Xiao-Cheng Wu, MD, MPH; Qingzhao Yu, PhD; Yong Yi, MS, PhD; Lauren S. Maniscalco, MPH; Mei-Chin Hsieh, MSPH, PhD; Suki Subbiah, MD; Pratibha Shrestha, MPH; Vivien W. Chen, PhD; Eileen T Mederos, RN; and Augusto Ochoa, MD. Authors from the Louisiana Department of Health include DeAnn Gruber, PhD; Lee Mendoza, PhD; and Theresa Sokol, MPH.The research was supported by the National Cancer Institute’s COVID-19 supplement funds to LSU Health New Orleans’ Gulf South Minority/ Underserved Clinical Trials Network, the National Institute on Minority Health and Health Disparities, the National Cancer Institute’s SEER award to LSU Health New Orleans and the CDC-NPCR award to LSU Health New Orleans.
“The findings presented in this important publication are the result of an outstanding collaboration between the National Cancer Institute and the Louisiana Tumor Registry led by Dr. Wu,” says Dr. Augusto Ochoa, Principal Investigator of the Gulf South Minority/ Underserved Clinical Trials Network at LSU Health New Orleans and Director of its Stanely S. Scott Cancer Center. “This work demonstrates that COVID-19 infection exacerbates the health disparities caused by Cancer in the most underserved populations in our state. Therefore, it is our responsibility to work with the state and the NCI to build a world class NCI-Designated Cancer Center that can develop ways of addressing and resolving the inequalities created by COVID-19 and cancer.LSU Health New Orleans Louisiana Tumor Registry is a statewide population-based cancer registry authorized by law to collect data on all reportable cancer cases occurring among Louisiana residents. One of only 22 cancer registries in the country comprising the National Cancer Institute’s SEER Program, the Louisiana Tumor Registry at LSU Health New Orleans is considered to be one of the leading cancer registries in the nation.
______________________________________________________________________________________________________________ LSU Health Sciences Center New Orleans (LSU Health New Orleans) educates Louisiana's health care professionals. The state's health sciences university leader, LSU Health New Orleans includes a School of Medicine with campuses in Baton Rouge and Lafayette, the state's only School of Dentistry, Louisiana's only public School of Public Health, and Schools of Allied Health Professions, Nursing, and Graduate Studies. LSU Health New Orleans faculty take care of patients in public and private hospitals and clinics throughout the region. In the vanguard of biosciences research, the LSU Health New Orleans research enterprise generates jobs and enormous annual economic impact. LSU Health New Orleans faculty have made lifesaving discoveries and continue to work to prevent, advance treatment or cure disease. To learn more, visit http://www.lsuhsc.edu, http://www.twitter.com/LSUHealthNO, or http://www.facebook.com/LSUHSC.
Follow Us 
Leslie Capo
Office: 504-568-4806
Cell: 504-452-9166
lcapo@lsuhsc.edu